1
Disclosures
Jan 29, 2026 — Mar 23, 2026
Date Range
PRIME
Market Segment

Disclosures

DateTypeHeadlinePDF
Mar 23 Other CHUGAI PHARMACEUTICAL: Halts Development of GYM329 for SMA and FSHD PDF

Disclosure Types

Other: 1